Latest Updates on Lipid Management

Area of Science:

• Cardiology
• Vascular Medicine
• Pharmacology

Background:

• Atherosclerotic cardiovascular disease (ASCVD) is the primary cause of mortality globally.
• Despite proven benefits in primary and secondary prevention, cholesterol management is often suboptimal, with many patients failing to reach target levels.
• Under-treatment of high cholesterol contributes significantly to the ASCVD burden.

Purpose of the Study:

• To provide an updated review of lipid management strategies for ASCVD.
• To emphasize the clinical applications of various cholesterol-lowering drug classes.
• To inform healthcare professionals on optimizing lipid targets for cardiovascular risk reduction.

Main Methods:

• Literature review of recent clinical guidelines and research.
• Analysis of different classes of lipid-lowering therapies.
• Synthesis of evidence on the efficacy and safety of cholesterol management.

Main Results:

• ASCVD necessitates aggressive lipid management for effective prevention.
• Multiple classes of cholesterol-lowering agents are available, each with specific indications and benefits.
• Achieving target lipid levels remains a challenge in clinical practice.

Conclusions:

• Optimizing lipid management is crucial for reducing ASCVD incidence and mortality.
• A comprehensive understanding of available cholesterol-lowering agents is essential for personalized patient care.
• Further efforts are needed to improve treatment adherence and target attainment in patients at risk for ASCVD.